Meta Pixel

News and Announcements

Fintech company surviving a market crash and achieving over 13% returns year to date

  • Published July 07, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

We have now reached over a full 12 months of business operating in Australia and we are proud to be consistently still delivering returns for our clients.  In 2020 so far we have seen a terrible global pandemic that has wrought massive consequences for the global economy, tensions between the US & China among many other things, that have contributed to poor investment returns for the elite investor. Despite this we have still, on average, achieved over 13% returns year to date, EVEN surviving a market crash.  Our AI trading algorithm is working away in the background, analysing market fluctuations in order to make trading decisions to navigate the stormy investment weather.

Halcyon Global is continuing to work with investors classified as wholesale/sophisticated in Australia, Singapore and the UK.

Register Interest

 

Click here to view Halcyon’s June results.

About Halcyon Global

With offices in Australia, the UK and Singapore, Halcyon is a global firm set up to bring more of the world’s opportunities to the elite investor.

Being true innovators in the fintech space, we are passionate about bringing wholesale investors the newest ways to enhance their wealth creation ability.

The Halcyon trading algorithm is a true innovation. An AI system that provides real-time analysis across more than 37,000 different data points to drive more enlightened decision-making, and thus higher potential returns.

Their clients’ success is our success. Being a select group, their clients enjoy a rewarding relationship with Halcyon, and they thrive on helping their clients achieve their goals – not only in terms of their finances, but their potential future.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now